GlassScriptPhysician profile
Shailesh C Kadakia
NPI 1295767861
$2,129.54
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $624 · 2020: $661 · 2021: $829 · 2022: $15.41.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $445.94 | 2019-2022 | |
| Abbvie INC. | $356.17 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $206.44 | 2019-2021 | |
| Janssen Biotech, INC. | $169.77 | 2019-2021 | |
| Shionogi INC | $153.16 | 2019 | |
| Ferring Pharmaceuticals INC. | $139.49 | 2019-2021 | |
| Redhill Biopharma INC. | $127.35 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $95.67 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $86.52 | 2019 | |
| Alfasigma USA, INC. | $78.20 | 2020 | |
| Intercept Pharmaceuticals, INC. | $73.99 | 2019-2021 | |
| Celgene Corporation | $61.54 | 2021 | |
| Qol Medical, LLC | $33.82 | 2019-2021 | |
| Braintree Laboratories, INC. | $31.21 | 2020-2021 | |
| Romark Laboratories, Lc | $28.84 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.33 | 2021 | |
| Pfizer INC. | $13.99 | 2019 | |
| Ironwood Pharmaceuticals, INC | $13.11 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shailesh Kadakia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.